Greg Dane
Greg Dane retired from the Georgia Research Alliance in 2015 and continues to advise GRA portfolio companies. Prior to joining GRA, he was director of innovation in the Wallace H. Department of Biomedical Engineering at Georgia Tech and Emory University, where he was instrumental in commercializing numerous university-based medical technologies through licensing and startup creation.
Greg served for 10 years as president and CEO of three development-stage bioscience companies, and 15 years in senior management positions with Baxter Healthcare Corporation, including general manager of research and development in Europe.
Greg is a director of MedShape, Inc. and GRA start-up company NovAb. He served as director of Somatocor, VitaGen, Inc., Neocrin Company and Sensys Medical, Inc. He also served on the boards of Georgia Biomedical Partnership (now Georgia Bio), the Life Sciences Industry Council in Orange County, CA, and numerous university-affiliated life science research and commercialization organizations.
Greg holds a Bachelor of Science degree and a Masters in Engineering from Cornell University.
